Dimethyl sulfoxide - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for dimethyl sulfoxide and what is the scope of freedom to operate?

Dimethyl sulfoxide is the generic ingredient in two branded drugs marketed by Mylan Institutional and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for dimethyl sulfoxide. One supplier is listed for this compound.

Summary for dimethyl sulfoxide

US Patents:	0
Tradenames:	2
Applicants:	1
NDAs:	2
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	302
Clinical Trials:	34
Patent Applications:	5,512
What excipients (inactive ingredients) are in dimethyl sulfoxide?	dimethyl sulfoxide excipients list
DailyMed Link:	dimethyl sulfoxide at DailyMed

Recent Clinical Trials for dimethyl sulfoxide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Fondazione IRCCS San Gerardo dei Tintori	Phase 2
A.O. Ospedale Papa Giovanni XXIII	Phase 2
Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Phase 2

See all dimethyl sulfoxide clinical trials

Medical Subject Heading (MeSH) Categories for dimethyl sulfoxide

Cryoprotective Agents
Free Radical Scavengers
Solvents

Anatomical Therapeutic Chemical (ATC) Classes for dimethyl sulfoxide

G04BX	Other urologicals
G04B	UROLOGICALS
G04	UROLOGICALS
G	Genito-urinary system and sex hormones

M02AX	Other topical products for joint and muscular pain
M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M	Musculo-skeletal system

US Patents and Regulatory Information for dimethyl sulfoxide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Institutional	DIMETHYL SULFOXIDE	dimethyl sulfoxide	SOLUTION;INTRAVESICAL	076185-001	Nov 29, 2002		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Mylan Institutional	RIMSO-50	dimethyl sulfoxide	SOLUTION;INTRAVESICAL	017788-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for dimethyl sulfoxide

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Institutional	RIMSO-50	dimethyl sulfoxide	SOLUTION;INTRAVESICAL	017788-001	Approved Prior to Jan 1, 1982	3,549,770	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.